Expert Opinion on Therapeutic Targets

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Expert Opinion on Therapeutic Targets  
Abbreviated title (ISO 4)
Expert Opin. Ther. Targets
Discipline Pharmacology, therapeutics
Language English
Publication details
Publisher
Publication history
1997-present
Frequency Monthly
5.139
Indexing
ISSN 1472-8222 (print)
1744-7631 (web)
LCCN 2002243135
OCLC no. 49275520
Links

Expert Opinion on Therapeutic Targets is a monthly peer-reviewed medical journal publishing review articles and original papers on recently identified novel molecular drug targets across all therapy areas.

The journal evaluates molecules, signal pathways, receptors and other therapeutic targets and their potential as candidates for drug development. Articles in this journal focus on the molecular level and should not include clinical information on specific drugs

The audience consists of scientists, managers and decision makers in the pharmaceutical industry, academic researchers working in the field of molecular medicine and others closely involved in R&D.

The journal is published by Informa. The Editor in Chief of the journal is Professor Daniele Santini, University Campus Bio-Medico, Rome, Italy

Indexing[edit]

Expert Opinion on Therapeutic Targets ranks #18 of 254 in the Pharmacology & Pharmacy category in the 2014 ISI Journal Citation Reports. The journal has a 2014 impact factor of 5.139.

The journal is indexed by Chemical Abstracts, Index Medicus/MEDLINE, ISI Alerting Services™, Science Citation Index Expanded, EMBASE/Excerpta Medica